Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001079973-06-000218
Filing Date
2006-04-13
Accepted
2006-04-13 11:19:59
Documents
2
Period of Report
2006-04-13
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT apnb_8ka-041306.htm 8-K/A 11456
2 EXHIBIT 99.1 apnb_8ka-ex991.htm EX-99.1 3935
  Complete submission text file 0001079973-06-000218.txt   17031
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-50019 | Film No.: 06757580
SIC: 2835 In Vitro & In Vivo Diagnostic Substances